ARTELO BIOSCIENCES, INC. Payments for Repurchase of Initial Public Offering
ARTELO BIOSCIENCES, INC. (ARTL) reported Payments for Repurchase of Initial Public Offering of $75.00 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfInitialPublicOffering · last filed 2025-11-12
- ARTELO BIOSCIENCES, INC. payments for repurchase of initial public offering for the quarter ending 2025-09-30 was $0.00.
- ARTELO BIOSCIENCES, INC. payments for repurchase of initial public offering for the quarter ending 2025-06-30 was $0.00.
- ARTELO BIOSCIENCES, INC. payments for repurchase of initial public offering for the quarter ending 2025-03-31 was $75.00M.
- ARTELO BIOSCIENCES, INC. payments for repurchase of initial public offering for the quarter ending 2024-12-31 was $0.00.
| Period end | Payments for Repurchase of Initial Public Offering 3 month | Payments for Repurchase of Initial Public Offering 6 month | Payments for Repurchase of Initial Public Offering 9 month | Payments for Repurchase of Initial Public Offering 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $75.00M 10-Q · filed 2025-11-12 | $75.00M derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 8-K 3 month · filed 2025-08-13 | $75.00M 10-Q · filed 2025-08-13 | $75.00M derived: sum of 3 quarters · filed 2025-08-13 | $75.00M derived: sum of 4 quarters · filed 2025-08-13 |
| 2025-03-31 | $75.00M 8-K · filed 2025-07-11 | $75.00M derived: sum of 2 quarters · filed 2025-07-11 | $75.00M derived: sum of 3 quarters · filed 2025-07-11 | |
| 2024-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2025-07-11 | $0.00 derived: sum of 2 quarters · filed 2025-07-11 | $75.00M 8-K · filed 2025-07-11 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $75.00M 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $75.00M 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |